Our Consultants, Your Partners
Howard L. Levine, Ph.D.
Founder, President, and Principal Consultant
Howard Levine has over 30 years of experience in successful product companies and as founder of BioProcess Technology Consultants, Inc., the leading CMC consulting group in the biopharmaceutical industry. In addition to leading BioProcess Technology Consultants, Dr. Levine is also Managing Director of BPTC Europe, a wholly owned subsidiary of BioProcess Technology Consultants, established in September 2010 to provide local consulting services to the European Community. Prior to founding BioProcess Technology Consultants, Dr. Levine was Vice President of Manufacturing Operations at Repligen Corporation where he was responsible for all process development and manufacturing activities, including production of therapeutic proteins, monoclonal antibodies and recombinant Protein A. Dr. Levine was previously Director, Pilot Plant Operations at Xoma Corporation where he was responsible for the development and manufacture of monoclonal antibody products for clinical trial. He has also held positions in process development and manufacturing at Genentech and Amgen. Throughout his career, Dr. Levine has assisted in the development of over 20 different biological products and the successful commercialization of three of these products. Dr. Levine is currently a member of the Editorial Advisory Boards of the Journal of Preparative Biochemistry and Biotechnology, BioPharm Magazine, and Bio/Pharmaceutical Outsourcing Report. He is also a member of the Scientific Advisory Boards of Pall Corporation and Biologics Process Development, Inc., and a member of the Board of Directors of Protein Sciences Corporation. Dr. Levine has been an invited lecturer on manufacturing strategy, downstream processing, and commercialization of biotechnology products. He holds a Ph.D. in chemistry from the University of Chicago and completed a post-doctoral fellowship at Harvard University.